Kevin Prussia is a partner in the firm’s Litigation/Controversy Department, a member of the Intellectual Property Litigation and Trial Practice Groups, and a member of the firm’s Management Committee. 

Mr. Prussia is an experienced litigator and trial lawyer, with significant experience representing leading life sciences and technology companies in major disputes involving intellectual property and other commercial matters. Mr. Prussia has experience across every aspect of trial and appellate practice, including bench and jury federal trials, International Trade Commission investigations, Patent Trial and Appeal Board proceedings, and appeals to the United States Court of Appeals for the Federal Circuit and the Supreme Judicial Court of Massachusetts. He is a true “stand-up” litigator who has handled challenging witness examinations and oral arguments for clients in high stakes litigations. He has successfully tried cases to verdict and has counseled numerous clients through complicated settlement discussions.

More than a litigator, Mr. Prussia’s practice also encompasses strategic advice and opinion work. He counsels clients regarding FDA issues, patent-portfolio evaluations, and licensing strategies. 

Outside of the courtroom, Mr. Prussia is a prominent member of the community. He has served on the Board of Directors for the ACLU of Massachusetts for ten years and currently serves as Chair of the Foundation. Mr. Prussia was previously President of the Board from 2015-2019. In addition, Mr. Prussia serves on the Advisory Board for the Center for Law, Brain and Behavior at Massachusetts General Hospital, as well as the Dean’s Advisory Council of the College of Arts and Science at NYU. Mr. Prussia is also a part-time faculty member at Boston University School of Law, where he teaches Patent Trial Advocacy.

Mr. Prussia has a deep civil rights pro bono practice. He currently represents a class of individuals in a high profile immigration case against the Department of Homeland Security. He is also a monitor for one of the country’s oldest consent decrees governing the hiring practices of entry-level police and firefighters in communities across Massachusetts. 



  • Honored with the Boston Bar Association's Thurgood Marshall award, which recognizes Boston attorneys for their “extraordinary efforts to enhance the human dignity of others through improving, developing or delivering civil or criminal legal services to low-income clients.”
  • Named to the Minority Corporate Counsel Association's 2023 list of Rainmakers, which recognizes individuals for their professional achievements and commitment to improving their community.
  • Featured in Savoy Magazine’s 2022 Most Influential Black Lawyers list, which focuses on top lawyers, showcasing visionaries, leaders and advocates—including partners and corporate counsel—from national law firms and Fortune 1000 companies who are widely recognized for their professionalism, protection of rights and community service.
  • Named a "Future Star" by Benchmark Litigation in 2022 and 2024.
  • Shortlisted as a 2019 US Rising Star in intellectual property by LMG Life Sciences.
  • Recognized among The National Bar Association's 2018 "40 Under 40 Nation's Best Advocates."
  • Named to The National Law Journal's 2015 list of Boston Rising Stars.
  • Named a Massachusetts Super Lawyers "Rising Star" for intellectual property law in the 20142016 issues of Boston Magazine.
  • Awarded the Civil Rights Pro Bono Recognition Award from the Lawyers' Committee for Civil Rights and Economic Justice in 2013.
  • Named to the Lawdragon 500 Leading Litigators in America list.

Insights & News


  • Education

    • JD, Boston University School of Law, 2006

      Executive Editor, American Journal of Law & Medicine
    • BA, Politics, New York University, 2001

  • Admissions

    • Massachusetts

    • New York

  • Clerkships

    • The Hon. Richard G. Stearns, US District Court for the District of Massachusetts, 2007 - 2008



Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.